• S2 Ep38: Claris Bio's journey toward treating neurotrophic keratitis

  • Apr 25 2024
  • Length: 6 mins
  • Podcast

S2 Ep38: Claris Bio's journey toward treating neurotrophic keratitis  By  cover art

S2 Ep38: Claris Bio's journey toward treating neurotrophic keratitis

  • Summary

  • Claris CEO, Clarke Atwell, gives an update on the company and their path toward developing treatment for neurotrophic keratitis
    Show more Show less
activate_primeday_promo_in_buybox_DT

What listeners say about S2 Ep38: Claris Bio's journey toward treating neurotrophic keratitis

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.